Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRBU
#3068
Caribou Biosciences, Inc. Common Stock
1.9
0
-1.55%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-1.55%
Mudança mensal
+21.79%
Mudança em 6 meses
-5.94%
Mudança anual
+62.39%
Fechamento anterior
1.9
3
Open
1.9
0
Bid
Ask
Low
1.9
0
High
1.9
0
Volume
25
Mercados
Ações
Cuidados de saúde
CRBU
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
90.55 M
93 M
93 M
93.12 M
93.47 M
—
Valuation ratios
Enterprise value
145.51 M
131.58 M
55.51 M
92.13 M
206.64 M
485.86 M
Price to earnings ratio
-1.24
-0.96
-0.56
-0.71
-1.37
-3.61
Price to sales ratio
14.4
14.37
8.37
12.67
23.16
58.57
Price to cash flow ratio
1.37
1.04
0.6
0.87
1.71
4.22
Price to book ratio
0.13
0.57
0.08
0.13
0.28
1.05
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.1
0.11
0.15
0.24
0.14
0.65
Return on equity %
0.12
0.14
0.18
0.33
0.19
0.84
Return on invested capital %
140.93
148.48
215.16
—
301.94
—
Gross margin %
100
100
100
100
100
400
Operating margin %
1 889.23
1 871.69
1 823.76
1 783.95
1 337.58
6 816.98
EBITDA margin %
—
—
—
—
—
—
Net margin %
1 713.64
1 708.71
1 699.58
2 028.42
1 253.32
6 690.03
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.38
7.16
7.63
6.66
5.54
26.99
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.01
0.01
0.01
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
—
—
—
—
Long term debt to total equity ratio
—
0
—
—
—
—
Per share metrics
Operating cash flow per share
0.36
0.39
0.4
0.3
0.27
1.36
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
3.11
2.76
2.29
1.98
1.71
8.74
Net current asset value per share
2.62
2.43
2.34
2.07
1.67
8.51
Tangible book value per share
3.11
2.8
2.34
1.79
1.52
8.45
Working capital per share
2.27
2.09
2.04
1.76
1.37
7.25
Book value per share
3.11
2.8
2.34
1.79
1.52
8.45
Notícias
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
CLO da Caribou Biosciences vendeu US$ 13.598 em ações da CRBU
Caribou Biosciences CLO sold $13,598 in CRBU stock
CTO da Caribou Biosciences vende US$ 6,1 mil em ações
Caribou Biosciences CTO Kelly sells $6.1k in shares
CMO da Caribou Biosciences vende US$ 2,1 mil em ações CRBU
Khan, diretor de negócios da Caribou Biosciences, vende US$ 13.598 em ações
Caribou Biosciences CMO sells $2.1k in CRBU stock
Khan, Caribou Biosciences CBO, sells $13598 in stock
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates
Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year?